Diagnostic utility of nestin expression in pediatric tumors in the region of the kidney

Applied Immunohistochemistry and Molecular Morphology

Volumn 17, Issue 6, 2009, Pages 517-523

  Murphy, Amanda J ^a   Viero, Sandra ^a,b   Ho, Michael ^a   Thorner, Paul Scott ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Clear cell sarcoma; Mesoblastic nephroma; Nestin; Renal cell carcinoma; Wilms; WT1

Indexed keywords

NESTIN;

ARTICLE; BLASTEMA; DESMOPLASTIC SMALL ROUND CELL TUMOR; EWING SARCOMA; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY SARCOMA; MAJOR CLINICAL STUDY; MESOBLASTIC NEPHROMA; NEPHROBLASTOMA; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOID TUMOR; RHABDOMYOSARCOMA; SENSITIVITY AND SPECIFICITY;

BONE NEOPLASMS; CARCINOMA, RENAL CELL; CHILD; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KIDNEY; KIDNEY NEOPLASMS; NERVE TISSUE PROTEINS; SARCOMA, EWING'S; TUMOR MARKERS, BIOLOGICAL; WILMS TUMOR; WT1 PROTEINS;

EID: 74249083387     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181a3259e     Document Type: Article

References (36)

1. Hockfield S, McKay RD. Identification of major cell classes in the developing mammalian nervous system. J Neurosci. 1985;5: 3310-3328.
2. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell. 1990;60:585-595.
3. Sejersen T, Lendahl U. Transient expression of the intermediate filament nestin during skeletal muscle development. J Cell Sci. 1993;106 (Pt 4):1291-1300.
4. Wagner N, Wagner KD, Scholz H, et al. Intermediate filament protein nestin is expressed in developing kidney and heart and might be regulated by the Wilms' tumor suppressor Wt1. Am J Physiol Regul Integr Comp Physiol. 2006;291:R779-R787.
5. Mokry J, Cizkova D, Filip S, et al. Nestin expression by newly formed human blood vessels. Stem Cells Dev. 2004;13:658-664.
6. Takano T, Becker LE. Developmental change of the nestinimmunoreactive midline raphe glial structure in human brainstem and spinal cord. Dev Neurosci. 1997;19:202-209.
7. Almqvist PM, Mah R, Lendahl U, et al. Immunohistochemical detection of nestin in pediatric brain tumors. J Histochem Cytochem. 2002;50:147-158.
8. Chen J, Boyle S, Zhao M, et al. Differential expression of the intermediate filament protein nestin during renal development and its localization in adult podocytes. J Am Soc Nephrol. 2006; 17:1283-1291.
9. Perry J, Ho M, Viero S, et al. The intermediate filament nestin is highly expressed in normal human podocytes and podocytes in glomerular disease. Pediatr Dev Pathol. 2007;10:369-382.
10. Strojnik T, Rosland GV, Sakariassen PO, et al. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol. 2007;68:133-143; discussion 143-1134
11. Brychtova S, Fiuraskova M, Hlobilkova A, et al. Nestin expression in cutaneous melanomas and melanocytic nevi. J Cutan Pathol. 2007;34:370-375.
12. Kobayashi M, Sjoberg G, Soderhall S, et al. Pediatric rhabdomyosarcomas express the intermediate filament nestin. Pediatr Res. 1998;43:386-392.
13. Korja M, Finne J, Salmi TT, et al. Chromogenic in situ hybridization-detected hotspot MYCN amplification associates with Ki-67 expression and inversely with nestin expression in neuroblastomas. Mod Pathol. 2005;18:1599-1605.
14. Olsen SH, Thomas DG, Lucas DR. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma. Mod Pathol. 2006;19:659-668.
15. Dahlstrand J, Collins VP, Lendahl U. Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res. 1992;52:5334-5341.
16. Somers GR, Zielenska M, Abdullah S, et al. Expression of MYCN in pediatric synovial sarcoma. Mod Pathol. 2007;20:734-741.
17. Tabori U, Ma J, Carter M, et al. HTERT expression predicts progression and survival in pediatric intracranial ependymoma. J Clin Oncol. 2006;24:1522-1528.
18. Murphy WM, Grignon DJ, Perlman EJ. Kidney tumors in children: tumors of the kidney, bladder, and related urinary structures atlas of tumor pathology fourth series; fascicle 1. Washington, DC: American Registry of Pathology; 2004:1-99.
19. Argani P, Perlman EJ, Breslow NE, et al. Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol. 2000;24:4-18.
20. Rubin BP, Chen CJ, Morgan TW, et al. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol. 1998;153:1451-1458.
21. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159: 179-192.
22. Delattre O, Zucman J, Plougastel B, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 1992;359:162-165.
23. Sorensen PH, Lessnick SL, Lopez-Terrada D, et al. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet. 1994;6: 146-151.
24. Joshi VV. Peripheral neuroblastic tumors: pathologic classification based on recommendations of international neuroblastoma pathology committee (Modification of shimada classification). Pediatr Dev Pathol. 2000;3:184-199.
25. Schwab M, Ellison J, Busch M, et al. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci USA. 1984;81:4940-4944.
26. Davis RJ, D'Cruz CM, Lovell MA, et al. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res. 1994;54:2869-2872.
27. Galili N, Davis RJ, Fredericks WJ, et al. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet. 1993;5:230-235. (Pubitemid 23330384)
28. Ladanyi M, Gerald W. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res. 1994;54: 2837-2840.
29. Gerald WL, Miller HK, Battifora H, et al. Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am J Surg Pathol. 1991;15:499-513.
30. Tsokos M, Kouraklis G, Chandra RS, et al. Malignant rhabdoid tumor of the kidney and soft tissues. Evidence for a diverse morphological and immunocytochemical phenotype. Arch Pathol Lab Med. 1989;113:115-120.
31. Carpentieri DF, Nichols K, Chou PM, et al. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors. Mod Pathol. 2002;15: 1080-1086.
32. Gerald WL, Gramling TS, Sens DA, et al. Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor. Am J Pathol. 1992;140:1031-1037.
33. Shao L, Hill DA, Perlman EJ. Expression of WT-1, Bcl-2, and CD34 by primary renal spindle cell tumors in children. Pediatr Dev Pathol. 2004;7:577-582.
34. Ramani P, Cowell JK. The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours. J Pathol. 1996;179:162-168.
35. Thomas SK, Messam CA, Spengler BA, et al. Nestin is a potential mediator of malignancy in human neuroblastoma cells. J Biol Chem. 2004;279:27994-27999.
36. Wiese C, Rolletschek A, Kania G, et al. Nestin expression-a property of multi-lineage progenitor cells? Cell Mol Life Sci. 2004;61:2510-2522.